Previously Issued Condensed Consolidated Financial Statements - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Aug. 11, 2025 |
May 22, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | ||||||
| Income tax expense (benefit) | $ 9,448 | $ 29,925 | $ 55,668 | $ 64,132 | ||
| Adjustments | ||||||
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | ||||||
| Income tax expense (benefit) | 27,271 | 27,271 | ||||
| Deferred income tax liabilities, net | $ 27,300 | $ 27,300 | ||||
| Public Offering And Private Placement | ||||||
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | ||||||
| Sale of stock, number of shares (in shares) | 18,823,500 | 13,207,142 | ||||
| X | ||||||||||
- Definition Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|